Centene Corporation (CNC)
NYSE: CNC · Real-Time Price · USD
26.95
-0.12 (-0.44%)
Aug 14, 2025, 2:14 PM - Market open
Centene Revenue
Centene had revenue of $42.84B in the quarter ending June 30, 2025, with 17.57% growth. This brings the company's revenue in the last twelve months to $159.56B, up 10.57% year-over-year. In the year 2024, Centene had annual revenue of $147.17B with 4.09% growth.
Revenue (ttm)
$159.56B
Revenue Growth
+10.57%
P/S Ratio
0.09
Revenue / Employee
$2,637,355
Employees
60,500
Market Cap
13.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 147.17B | 5.78B | 4.09% |
Dec 31, 2023 | 141.39B | 5.39B | 3.97% |
Dec 31, 2022 | 136.00B | 17.43B | 14.70% |
Dec 31, 2021 | 118.57B | 14.29B | 13.71% |
Dec 31, 2020 | 104.28B | 33.47B | 47.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CNC News
- 5 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 8, 2025 in Centene Lawsuit - CNC - PRNewsWire
- 6 hours ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene - PRNewsWire
- 21 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 8, 2025 in Centene Corporation Lawsuit – CNC - GlobeNewsWire
- 1 day ago - Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman - GlobeNewsWire
- 1 day ago - CENTENE STOCK: Lose Money on Your Centene Corporation (NYSE:CNC) Investment? Contact BFA Law before the September 8 Legal Deadline - GlobeNewsWire
- 2 days ago - CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm - PRNewsWire
- 2 days ago - Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CNC - PRNewsWire
- 3 days ago - CNC COURT NOTICE: Centene Corporation Investors may have been Affected by Fraud -- Contact BFA Law before September 8 if You Suffered Losses (NYSE:CNC) - GlobeNewsWire